Main menu

You are here

COVID-19 patients who could benefit from Paxlovid find price shock

Primary tabs

Mon, 2024-03-11 11:26 — mike kraft

COVID-19 patients who could most benefit from Paxlovid still aren’t getting it - UPI.com Sticker shock has stunned thousands of Americans sick with COVID-19 since late December, as Pfizer shifted to commercial sales of Paxlovid. Before then, the federal government covered the cost of the drug. UPI

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments